BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 27501915)

  • 1. The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
    Wirsching HG; Weller M
    Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of gliomas: potential therapeutic implications.
    Alentorn A; Duran-Peña A; Pingle SC; Piccioni DE; Idbaih A; Kesari S
    Expert Rev Anticancer Ther; 2015; 15(8):955-62. PubMed ID: 26118895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
    Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
    Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplastic gliomas in adults: an update.
    Izquierdo C; Joubert B; Ducray F
    Curr Opin Oncol; 2017 Nov; 29(6):434-442. PubMed ID: 28901965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Misclassification of Diffuse Gliomas: Rates and Outcomes.
    Iorgulescu JB; Torre M; Harary M; Smith TR; Aizer AA; Reardon DA; Barnholtz-Sloan JS; Perry A
    Clin Cancer Res; 2019 Apr; 25(8):2656-2663. PubMed ID: 30635340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification.
    Ochirjav E; Enkhbat B; Baldandorj T; Choe G
    J Pathol Transl Med; 2019 Sep; 53(5):298-307. PubMed ID: 31370384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Classification of gliomas. Current progress and perspectives].
    Capper D; Reifenberger G
    Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Considerations in the Treatment of Grade 3 Gliomas.
    Jo J; Schiff D
    Curr Treat Options Oncol; 2022 Sep; 23(9):1219-1232. PubMed ID: 35913658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological diagnosis of gliomas by genotype analysis].
    Nakamura M; Shimada K; Nakase H; Konishi N
    Brain Nerve; 2009 Jul; 61(7):773-80. PubMed ID: 19618854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
    van den Bent MJ; Smits M; Kros JM; Chang SM
    J Clin Oncol; 2017 Jul; 35(21):2394-2401. PubMed ID: 28640702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma Subclassifications and Their Clinical Significance.
    Chen R; Smith-Cohn M; Cohen AL; Colman H
    Neurotherapeutics; 2017 Apr; 14(2):284-297. PubMed ID: 28281173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Basic principles of diagnosis and treatment of gliomas].
    Wirsching HG; Weiss T; Roth P; Weller M
    Nervenarzt; 2018 Jun; 89(6):692-698. PubMed ID: 29679127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of anaplastic glioma.
    Wick W; Wiestler B; Platten M
    Cancer Treat Res; 2015; 163():89-101. PubMed ID: 25468227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular neuropathology of gliomas.
    Riemenschneider MJ; Reifenberger G
    Int J Mol Sci; 2009 Jan; 10(1):184-212. PubMed ID: 19333441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive biomarkers in adult gliomas: the present and the future.
    Thomas L; Di Stefano AL; Ducray F
    Curr Opin Oncol; 2013 Nov; 25(6):689-94. PubMed ID: 24076583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
    Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
    Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic Glioma: Treatment Approaches in the Era of Molecular Diagnostics.
    Ruff MW; Uhm J
    Curr Treat Options Oncol; 2018 Oct; 19(12):61. PubMed ID: 30361986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
    Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
    Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnostics of gliomas: the clinical perspective.
    Tabatabai G; Stupp R; van den Bent MJ; Hegi ME; Tonn JC; Wick W; Weller M
    Acta Neuropathol; 2010 Nov; 120(5):585-92. PubMed ID: 20862485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.